EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies

Yushan Yao, Kang Li, Yinghui Chai, Xianping Deng, Min Li, Junya Lan, Yan Liang, Xueqiong Wu, Hong Lei

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1663992 ↗

At a glance

Übersichtsarbeit in Frontiers in Cellular and Infection Microbiology, 2025. Written by Yushan Yao and 8 co-authors. Institution: The Eighth Medical Center of PLA General Hospital, Beijing, China. Major MEDLINE topics: Mycobacterium tuberculosis, Tuberculosis, MAP Kinase Signaling System, Host-Pathogen Interactions. Cited 9 times so far (Crossref); 148 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Tuberculosis (TB), which is caused by Mycobacterium tuberculosis ( Mtb), remains a major infectious disease worldwide. Despite the availability of anti-TB drugs, the emergence of drug resistance, the need for prolonged treatment duration and the occurrence of side effects highlight the urgent need for new therapeutic strategies. The c-Jun N-terminal kinase (JNK) signaling pathway, which is an important member of the mitogen-activated protein kinase (MAPK) family, plays a crucial role in regulating cellular stress responses, inflammation, apoptosis, autophagy, and ferroptosis. Excessive JNK activation can induce uncontrolled inflammation, tissue damage, and chronic immune activation. In contrast, insufficient activation may impair the host’s defense, facilitating Mtb immune evasion and persistence. Such alterations disrupt the delicate immune equilibrium essential for effective pathogen clearance and host protection. This review summarizes the molecular mechanisms through which Mtb manipulates the JNK signaling pathway to disrupt host immunity, emphasizing its roles in metabolic reprogramming, apoptosis, autophagy, and ferroptosis. In addition, this review discusses potential therapeutic strategies targeting the JNK pathway, including the development of selective JNK inhibitors, with a focus on their prospects in TB treatment. Progress has been made in elucidating the role of JNK signaling pathway in TB, but further research is required to clarify its specific mechanisms and evaluate the safety and efficacy of JNK-targeted interventions. Continued exploration of this pathway may provide new targets and strategies for TB therapy.

Subjects

MeSH terms (MEDLINE)

Mycobacterium tuberculosisTuberculosisMAP Kinase Signaling SystemHost-Pathogen InteractionsJNK Mitogen-Activated Protein KinasesHumansAutophagyAntitubercular AgentsApoptosisAnimalsSignal TransductionFerroptosis

Author keywords

JNK inhibitorsJNK signaling pathwayMTBimmune evasionimmune responseinflammationtherapeutic strategies

Substances

Antitubercular AgentsJNK Mitogen-Activated Protein Kinases

Authors and institutions

  • The Eighth Medical Center of PLA General Hospital, Beijing, China.
  • Hebei North University, Zhangjiakou, China.

Cite

APA

Yao, Y., Li, K., Chai, Y., Deng, X., Li, M., Lan, J., Liang, Y., Wu, X., & Lei, H. (2025). Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1663992

Vancouver

Yao Y, Li K, Chai Y, Deng X, Li M, Lan J, et al. Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1663992

BibTeX
@article{Yao2025,
  author = {Yao, Yushan and Li, Kang and Chai, Yinghui and Deng, Xianping and Li, Min and Lan, Junya and Liang, Yan and Wu, Xueqiong and Lei, Hong},
  title = {Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1663992}
}
Start for free →